Non‐alcoholic steatohepatitis (NASH) has been recognized as a major catalyst of HCC, and the hepatocyte‐specific deletion of SMARCA4 relieves MCD‐induced NASH in mice.138, 139, 140. The gene discussed is SMARCA4; the disease is metabolic dysfunction-associated steatohepatitis.